图片来源:图虫创意2月21日,先声药业(02096.HK)发布盈利预告,预计2024年实现收入约66.20亿元至66.50亿元,同比增幅约0.2%至0.6%;实现归属于本公司权益股东的利润约7.18亿元至7.48亿元,同比增幅约0.4%至4.6%。此外,公司预计2024年将取得的经调整归属于本公司权益股东的利润约10.03亿元至10.33亿元,同比增幅约39.5%至43.7%。先声药业表示,有关...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.